Resources
BNET Business Dictionary
- Human Resources
- the discipline of managing people in an organization.
- Human Resources definition on BNET »
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Transforming the Pharmaceutical Industry: Human Resources as Global Catalyst
- This paper discusses the post-merger transformation of the regional/country based Human Resources organizations of a multinational pharmaceutical company that will be referred to in this paper as APC A Pharmaceutical Company. APC initiated its integration planning in late 1999 with a global team-based organization that was the model for commercial,...
- Research articles 2007-07-01
- West Pharmaceutical Services
- West Pharmaceutical Services, Inc. (NYSE:WST) is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products. When an explosion ripped through its Kinston, N.C.,...
- Case studies
- Pharmaceuticals/Health Care: Safety and Security in the Spotlight
- This article discusses about the safety and security in healthcare and pharmaceutical sector. The U.S. business community?and society in general?have become markedly more security conscious following the havoc of 9/11, and this new awareness has spotlighted the vulnerability of food and drug supply chains. Regulatory watchdogs of the already highly...
- White papers 2004-06-01
- Caught in the Cross Chairs
- The pharmaceutical industry stands in the crosshairs of federal and state law enforcement agencies. It is not being targeted by FDA for regulatory violations, as one would expect, but by many other government agencies. Some of the issues in question are the way pharma companies calculate and report product prices...
- White papers 2002-04-15
- Pharma 2005 Marketing to the Individual
- The world in which all live is changing, and the PricewaterhouseCoopers Global Pharmaceutical Practice has taken on the challenge of exploring the future and its implications for today's pharmaceutical companies. From the forces converging on the individual to the acceleration of change due to the e-environment, we have explored multiple...
- White papers 2001-05-15
- Process Validation: Moist Heat Sterilization for Pharmaceuticals
- This document is intended to provide manufacturers of pharmaceutical dosage forms with guidance to establish the scientific effectiveness of moist heat sterilization processes, as required in Sections C.02.004, C.02.005, C.02.007, C.02.011 and C.02.029 of the Food and Drug Regulations. This guideline is applicable to moist heat sterilization processes only. While...
- White papers 2001-05-01
- Estimating the Effects of Pharmaceutical Innovations on Patient's Employment Outcomes
- As new medical technologies continue to drive the growing cost of health care in the United States, public and private decision makers have called for more rigorous evaluations of the costs and benefits of pharmaceuticals and other medical technologies. The common practice of ignoring employment benefits of treatment in the...
- White papers 2004-04-08
- The Human and Economic Value of Pharmaceutical Innovation and Opportunities for the NHS
- Innovation is vital in the health care system. Innovation can be about improving compliance with existing treatment regimes, bringing new ways of treating patients, providing their treatment more cost effectively, or expanding the boundaries of what can be treated. Innovation can come in many forms new medicines, different devices, improved...
- White papers 2004-05-07
- A Brief History of the GMPs for Pharmaceuticals
- A glance back at the achievements and the tragedies of the pharmaceutical industry reveals the importance of continuing compliance with current good manufacturing practices GMPs. To obtain and maintain GMP compliance, every manager and supervisor should provide frequent, meaningful GMP reminders, train and develop all employees, and fully participate in...
- White papers 2001-07-01
- High-Cost Users of Pharmaceuticals: Who Are They?
- For a long time that health care resources and costs are concentrated on a relatively small proportion of the population. These high-level consumers of health care have gained the negative reputation of being "high users" and provide an obvious target for cost containment. With the rising costs of pharmaceuticals over...
- White papers 2005-03-01
- The Coming Paradigm Shift in Pharmaceuticals
- This article explores the coming paradigm shift and the opportunities it presents for the future of pharmaceuticals. This article discusses how Pharmacogenomics holds the promise of more effective and better-tolerated therapies, which, in turn, mean more efficient use of healthcare resources. The article further goes on to discuss several hurdles...
- White papers 2002-09-30
- Demonstrating the Value of Pharmaceuticals Across the Healthcare Continuum
- This document debates and explores medical innovation and the role of pharmaceuticals in the delivery of high-quality healthcare. This article examines and discusses the trends in healthcare consumerism, FDA movements to ensure safety, improvements in disease-state outcomes, increases in quality of life, and the economics associated with all these complex...
- White papers 2004-02-01
- Dilemmas in Regulation of the Market for Pharmaceuticals
- This article focuses on the lessons learned from international experience of efforts to control spending and to improve efficiency and access in pharmaceutical markets? Policymakers tend to reinvent many policies to control the behavior of patients, doctors, and industry, despite a lack of evidence of those policies' cost-effectiveness. There is...
- White papers 2003-04-21
- A New Rx for Corporate Disclosure: Realizing Value in the Pharmaceutical and Healthcare Products Industries
- This paper focuses on the pharmaceutical and healthcare products industries. It identifies a significant number of opportunities for companies to improve their communications with investors and analysts and, thereby, disclose information to the capital markets that reveals their underlying value. It proposes a new reporting framework, which includes a set...
- White papers 2001-10-25
- The Relationship Between Salesperson Competencies and Performance in the Korean Pharmaceutical Industry
- This study investigates how competencies lead to performance. It proposes that salespersons in the Korean pharmaceutical industry require three central competency dimensions: motive and traits, self-concept, and knowledge and skills. Further, it argues that the level of salesperson competencies is positively related to his/her performance, and that the quality of...
- White papers 2005-01-15
- Canada and Brazil Dealing With Tension Between Ensuring Access to Medicines and Complying With Pharmaceutical Patent Standards: Is the Story the Same?
- Health is a primary good which is fundamental for any person's life. As a result, health care services generally and pharmaceutical services which is the focus of this research in particular are fundamental for the health of person and contribute to the essence of human life. From a practical point...
- White papers 2004-06-08
- U.S. Equity Strategy: The Health of Health Care
- This article reports on the latest state of the healthcare market. Recent negative news in the drug sector has pushed down pharmaceutical stocks and provides an entry point given attractive valuations and dividends, as well as relative 2006 EPS growth prospects. Seasonal trading patterns also should benefit both pharmaceutical and...
- White papers 2005-09-01
- Sundhed.dk Improves Quality and Access to Health Care for Denmark
- The Danish Pharmaceutical Association consists of 238 pharmacies that control all prescribed medications in the country. The Pharmaceutical Association was eager to collaborate with other nonprofit organizations to develop an Internet portal, www.sundhed.dk, to improve their business performance. The idea behind the website was to bridge the gap between the...
- Case studies
- Mid-sized Pharmaceutical Company
- The company, a mid-sized pharmaceutical company, asked Capgemini to help identify key performance measures and design & develop a Web-based system for publishing these measures. The project was executed in two phases. The first phase helped the client identify the performance measures most important to the Executive Management Team. During...
- Case studies
- Oxymoron No More: The Potential of Nonprofit Drug Companies to Deliver on the Promise of Medicines for the Developing World
- Although some pharmaceutical company efforts to develop and distribute drugs in developing countries have been successful, many fall short of meeting needs in resource-poor nations. The paper discusses the concept of a nonprofit pharmaceutical company dedicated to developing and distributing drugs for diseases endemic in developing countries. Using the experience...
- White papers 2005-08-01
- << Previous
- page 1 of 3
- Next >>
Content Types
Refining Tags
- Benefits (34 results)
- Vertical Industries (27 results)
- Enterprise Software (26 results)
- Software (26 results)
- Healthcare (26 results)
- Health Care (24 results)
- Jim Edwards (13 results)
- Workforce Management (12 results)
- John Maas (7 results)
- Manufacturing (6 results)
- Sales Strategy (5 results)
- Sales (5 results)
- Biotechnology (5 results)
- Pfizer Inc. (5 results)
- Recruitment & Selection (4 results)
- Women (4 results)
- Gender And Diversity (4 results)
- Job (4 results)
- Business Operations (4 results)
- Performance Management (3 results)
- Compensation (3 results)
- PricewaterhouseCoopers Consulting (3 results)
- Procter & Gamble Co. (3 results)
- CEO (3 results)
- Marketing (3 results)
- Viagra (3 results)
- Finance (3 results)
- Strategy (3 results)
- Performance (3 results)
- Research & Development (3 results)
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
